Related Experiment Video
Updated: Jan 16, 2026

06:30
Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats
Published on: May 23, 2025
900
Recent Advances in Smart Polymers-Based Therapeutics in Ophthalmology
Jia'nan Xie1, Lili Nie1, Ying Pei1
1Department of Ophthalmology, The Second Hospital of Jilin University, Changchun, 130000, People's Republic of China.
International Journal of Nanomedicine
|October 1, 2025
Summary
Smart polymer systems offer advanced drug delivery for ophthalmic diseases, improving treatment precision and reducing side effects. These stimuli-responsive systems enhance drug stability and localized distribution for better eye care.
Area of Science:
- Ophthalmology
- Materials Science
- Biomedical Engineering
Background:
- Ophthalmic diseases cause significant visual impairment and blindness globally.
- Conventional ocular drug delivery faces challenges due to the eye's unique barriers.
- Novel drug delivery systems are crucial for enhanced therapeutic benefits and reduced adverse effects.
Purpose of the Study:
- To review recent advancements in smart polymer-based drug delivery systems for ophthalmic applications.
- To highlight the potential of stimuli-responsive polymers in ocular therapeutics.
- To discuss improvements in drug stability, localized distribution, and patient adherence.
Main Methods:
- Review of current literature on smart polymer-based therapies in ophthalmology.
- Focus on stimuli-responsive, biodegradable, and multifunctional polymer systems.
- Analysis of dynamic drug release mechanisms triggered by pH, temperature, light, and enzymes.
Main Results:
- Smart polymer systems enable controlled and sustained drug release in ocular tissues.
- Stimuli-responsive polymers offer precise drug delivery, activated by specific physiological conditions.
- These systems enhance drug stability and achieve localized distribution, minimizing systemic exposure.
Conclusions:
- Smart polymer-based therapies represent a significant advancement in ocular drug delivery.
- These innovative systems hold the potential to transform the management of ophthalmic diseases.
- Further development promises improved therapeutic efficacy and patient compliance in eye care.

